PHAMIS INC /WA/
10-K/A, 1997-04-29
COMPUTER INTEGRATED SYSTEMS DESIGN
Previous: HOMEOWNERS FINANCIAL CORP, 10QSB, 1997-04-29
Next: ICAP FUNDS INC, 485BPOS, 1997-04-29



<PAGE>
 
                      SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C. 20549
                            ----------------------

                                  FORM 10-K/A
(MARK ONE)
     [X]     ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D)
                    OF THE SECURITIES EXCHANGE ACT OF 1934

                  For the fiscal year ended December 31, 1996

                                      OR

     [ ]     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D)
                    OF THE SECURITIES EXCHANGE ACT OF 1934

                FOR THE TRANSITION PERIOD FROM ______ TO ______

                       COMMISSION FILE NUMBER:  0-25078

                                 PHAMIS, INC.

            (Exact name of registrant as specified in its charter)

                WASHINGTON                          91-1141795
           (State or other jurisdiction of        (I.R.S. Employer
            incorporation or organization)      Identification Number)

     1001 FOURTH AVENUE PLAZA, SUITE 1500, SEATTLE, WASHINGTON    98154-1144
          (Address of principal executive offices)                (Zip Code)

     Registrant's telephone number, including area code:          (206) 622-9558

     Securities registered pursuant to Section 12(b) of the Act:       None

     Securities registered pursuant to Section 12(g) of the Act:  Common Stock

Indicate by check mark whether the registrant: (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. YES X NO 
                                              -    ---   

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405
of Regulation S-K is not contained herein, and will not be contained, to the
best of the registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K, or any
amendment to this Form 10-K. [ ]

The aggregate market value of the common stock held by non-affiliates of the
registrant as of March 1, 1997 was $88,998,062.

The number of shares outstanding of the registrant's common stock as of March 1,
1997 was 6,143,145.
<PAGE>
 
PART III

ITEM 10.  DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT

SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

     Under Section 16(a) of the Securities Exchange Act of 1934, as amended, and
the regulations thereunder, the Company's directors, executive officers and
beneficial owners of more than 10% of any registered class of Company equity
securities are required to file reports of their ownership, and any changes in
that ownership, to the SEC. Based solely on its review of copies of these
reports and on written representations from certain reporting persons, the
Company believes that during fiscal year 1996 such SEC filing requirements were
complied with, except for the following:

     1. Thomas Watson did not timely file a Form 4 report, which report was
     subsequently filed, to report an exercise of 10,000 shares of Common Stock
     under the PHAMIS, Inc. 1993 Nonqualified and Incentive Stock Option Plan.

     2. Thomas Watson did not timely file a Form 5 report, which report was
     subsequently filed, to report a grant of 7,500 shares of Common Stock under
     the PHAMIS, Inc. 1993 Combined Nonqualified and Incentive Stock Option
     Plan.

     3. Gregg Blodgett did not timely file a Form 5 report, which report was
     subsequently filed, to report a grant of 10,000 shares of Common Stock
     under the PHAMIS, Inc. 1993 Combined Nonqualified and Incentive Stock
     Option Plan.

     4. Laurie Pike did not timely file a Form 4 report, which report was
     subsequently filed, to report the sale of 4,000 shares of Common Stock.

                                      -2-
<PAGE>
 
ITEM 11.  EXECUTIVE COMPENSATION

SUMMARY COMPENSATION TABLE

     The following table and related notes set forth all compensation received
from the Company for the fiscal years ended December 31, 1996, 1995 and 1994, by
the Company's Chief Executive Officer ("CEO") and the four most highly paid
executive officers (other than the CEO) who were serving as executive officers
at the end of 1996 (collectively, together with the CEO, the "Named Executive
Officers").

<TABLE>
<CAPTION>
                                               Annual           Long-Term
                                            Compensation      Compensation
                                         ------------------   ------------          All
Name and                                                         Options           Other
Principal Position                Year    Salary     Bonus     Granted(#)     Compensation/(1)/
- -------------------------------   ----   --------   -------   ------------    -----------------
 
<S>                               <C>    <C>        <C>       <C>             <C>
Frank T. Sample................   1996   $245,008   $    --         15,000               $1,716
   President and Chief            1995    192,571    83,600         25,000                1,000
   Executive Officer              1994    183,808    53,100         10,000                1,000

Malcolm A. Gleser..............   1996    154,310        --          7,000                1,625
   Senior Vice President of       1995    146,079    45,494             --                7,000
   Corporate Research             1994    145,049    31,427             --                7,000
   Organization

Mark F. Wheeler................   1996    144,483        --          7,000                1,567
   Senior Vice President of       1995    128,599    40,052             --                5,460
   Corporate Research             1994    127,644    27,656             --                5,460
   Organization

Gregg W. Blodgett..............   1996    137,922        --          4,500                1,539
   Vice President of Finance      1995    113,917    37,191         10,000                  719
                                  1994     44,511    17,289         45,000                   --

Thomas M. Watson...............   1996    118,337    29,868          4,500                1,555
   Vice President of Sales        1995     99,353    59,144          7,500                1,000
                                  1994     92,231    55,000             --                1,000
</TABLE>

________________________

(1)  Amounts in this column include the following:

     (a)  Annual Company matching contributions, pursuant to the 401(k) Plan, of
          $1,500 for each of Messrs. Sample, Gleser, Wheeler, Blodgett and
          Watson in 1996, of $1,000 for each of Messrs. Sample, Gleser, Wheeler
          and Watson in 1995 and 1994, and of $719 for Mr. Blodgett in 1995.

     (b)  Annual payments of group term life insurance premiums on insurance
          policies in the following amounts: Frank Sample, $216, Dr. Gleser,
          $124, Dr. Wheeler, $66, Thomas Watson, $55 and Gregg Blodgett, $39 in
          1996, and for Drs. Gleser and Wheeler in the amounts of $6,000 and
          $4,460, respectively, for 1995 and 1994.

                                      -3-
<PAGE>
 
GRANTS OF STOCK OPTIONS IN 1996

The following table sets forth information on stock option grants during fiscal
1996 to the Named Executive Officers.

<TABLE>
<CAPTION>
 
     
                                                                                                     Potential Realizable Value at
                                                                                                     Assumed Annual Rates of Stock
                                                            Percent of                              Price Appreciation for Ten Year
                                                          Total Options                                    Option Term /(2)/
                                                            Granted to     Exercise
                                             Options       Employees in      Price     Expiration
Name                                      Granted /(1)/    Fiscal Year     ($/Share)      Date             5%($)            10%($)
- ---------------------------------------   -------------   --------------   ---------   ----------        --------          --------
 <S>                                       <C>             <C>              <C>         <C>          <C>              <C>

Frank T. Sample........................          15,000             6.9%     $24.00      01/25/06        $226,402          $573,747
Malcolm A. Gleser......................           7,000             3.2       24.00      01/25/06         105,654           267,749
Mark F. Wheeler........................           7,000             3.2       24.00      01/25/06         105,654           267,749
Gregg W. Blodgett......................           4,500             2.1       24.00      01/25/06          67,921           172,124
Thomas M. Watson.......................           4,500             2.1       24.00      01/25/06          67,921           172,124
</TABLE>
(1)  Each of the options reflected in this table was granted to the respective
     Named Executive Officer pursuant to the 1993 Option Plan. The exercise
     price of each option is equal to the fair market value of the Common Stock
     on the date of grant. The options have a ten year term and vest over five
     years. The exercise price may be paid in cash or in previously owned shares
     of Common Stock.

(2)  These assumed rates of appreciation are provided in order to comply with
     the requirements of the Securities and Exchange Commission (the "SEC") and
     do not represent the Company's expectation or projection as to the actual
     rate of appreciation of the Common Stock. These gains are based on assumed
     rates of annual compound stock price appreciation of 5% and 10% from the
     date the options were granted over the full option term. The actual value
     of the options will depend on the performance of the Common Stock and may
     be greater or less than the amounts shown.


OPTION EXERCISES IN 1996 AND YEAR-END OPTION VALUES

     The following table sets forth information on the exercise of stock options
during fiscal year 1996 by each of the Named Executive Officers and the value of
unexercised options at December 31, 1996.

<TABLE>
<CAPTION>
                                                          Number of Unexercised         Value of Unexercised
                          Shares                                Options                 In-the-Money Options
                         Acquired                        at Fiscal Year-End (#)      at Fiscal Year-End ($)/(2)/
                       on Exercise    Value Realized  ---------------------------   ---------------------------
Name                       (#)              ($)/(1)/   Exercisable   Unexercisable   Exercisable   Unexercisable
- --------------------   -----------    --------------   -----------   -------------   -----------   -------------
<S>                    <C>            <C>              <C>           <C>             <C>           <C>

Frank T. Sample.....        23,500         $ 287,625       119,582          32,418      $923,136        $ 38,614
Malcolm A. Gleser...            --                --         1,283           5,717            --              --
Mark F. Wheeler.....            --                --         1,283           5,717            --              --
Gregg W. Blodgett...         2,000            37,420        19,658          33,842       102,525         164,040
Thomas M. Watson....        23,000           271,750        14,251           9,259        90,069           7,745
 
</TABLE>

(1)  Amounts equal the closing price of the Common Stock on the date of exercise
     less the option exercise price, multiplied by the number of shares acquired
     upon exercise.

(2)  Amounts equal the closing price of the Common Stock on December 31, 1996
     ($12.875 per share), less the option exercise price, multiplied by the
     number of shares exercisable or unexercisable.

                                      -4-
<PAGE>
 
REPORT OF THE COMPENSATION COMMITTEE

     The Compensation Committee (the "Committee") is composed of independent
non-employee directors. The Committee makes recommendations to the Board of
Directors regarding the administration of compensation for executive officers
and the terms and conditions of their employment. The Committee also administers
the Company's 1993 Option Plan and, among other matters, approves grants of
options under such 1993 Option Plan.

                            COMPENSATION PHILOSOPHY

     The Committee and the Board of Directors believe that the compensation of
the CEO and other executive officers should be aligned with the performance of
the Company and the value that is created for its shareholders. To motivate
executive officers to the greatest extent possible to achieve such performance,
the Committee and the Board of Directors believe a significant portion of
compensation should be incentive based.

     In addition, the Committee endeavors to insure that the compensation
programs for executive officers of the Company are effective in attracting and
retaining key executives responsible for the success of the Company and the
promotion of its long-term interests and those of its stockholders.

                           ELEMENTS OF COMPENSATION

     Compensation is individually set for each executive officer from a number
of components. The primary elements of executive compensation currently being
utilized are base salary, annual cash performance bonuses and long-term stock
options. The Committee believes that a significant portion of each year's
compensation for executive officers should be subject to incentive criteria. The
Committee also believes that long-term, stock-based compensation arrangements
for executive officers are beneficial in aligning management's and shareholders'
interests in the growth of shareholder value.

     At the beginning of the 1996 fiscal year, the Company engaged a nationally
recognized compensation consulting firm ("Consultant") to assist management and
the Committee. Such Consultant utilized a number of survey sources to conduct a
compensation analysis, comparing the Company to a number of companies in the
high technology industry on a nationwide basis. The survey sources overlapped,
but were not identical with the peer group indices used for the performance
graph located elsewhere in this Proxy Statement. The scope of the Consultant's
analysis for the Company included a competitive analysis of senior management
base salaries, annual cash performance bonuses and long-term stock options. The
Committee relied significantly on such Consultant's recommendations in
determining the various elements of executive compensation, as described in
further detail below.

     The Company has also adopted certain broad-based employee benefit plans in
which executive officers are eligible to participate. These include a 401(k)
Plan, medical benefit plans and a Company-wide stock purchase plan.

                                 BASE SALARIES

     Base salaries for executive officers are established for each fiscal year
at the beginning of the year following a review of both the Company's
performance and the individual executive officer's performance during the prior
fiscal period. The CEO makes recommendations to the Committee with regard to all
annual base salaries other than his own.

     For 1996, base salaries for all executive officers were generally targeted
at the market median for what the Company believed was its competition.  For
this purpose, in setting 1996 base salaries, the Committee considered its market
competition to be other national computer systems and software companies with
comparable annual revenues.

     Individual base salary increases for executive officers, other than the
CEO, were based on a review of the executive compensation recommendations
received from its retained Consultant, the actual previous salaries of the
executives and the CEO's recommendations with regard to such officers.

                                      -5-
<PAGE>
 
                            ANNUAL PERFORMANCE BONUS

     For 1996, the Committee adopted a bonus program by which executive
officers, including the CEO, could be eligible for substantial cash bonuses for
individual performance demonstrated during the 1996 fiscal year.

     The initial component of the bonus program involved setting a percentage of
base salary which would be a target bonus payment for each executive officer.
For 1996, the Committee decided that all executive officers other than the CEO
and the Vice President of Sales would be eligible to receive a performance bonus
equal to 30% of their annual base salary. The Committee determined the 30%
target bonus computation to be an appropriate amount of annual performance
incentive, based primarily on a recommendation from the Consultant that such
target bonus level was consistent with cash bonus levels among other surveyed
companies. The Vice President of Sales was provided with a separate bonus and
commission arrangement determined solely on Company net income and customer
bookings which is not limited to 30%, of his annual base salary.

     Target cash bonuses under the bonus program were conditioned on the
Company's attainment of a threshold level of 1996 annual net income, before
taxes and non-recurring charges and before taking into effect any bonus
payments. If such a threshold level of Company performance was not met, then
executive officers would not be eligible to receive a bonus. If such threshold
level was met, then each executive officer would be eligible to earn all or a
portion of his or her target bonus for the year. In addition, if a higher excess
level of 1996 annual net profits before taxes, non-recurring charges and bonus
payments was achieved, then each executive officer would be eligible to receive
150% of his or her target bonus for the year.

     Each individual bonus was additionally contingent on the attainment of
various business objectives by each executive officer. At the beginning of 1996
the individual bonus criteria for each executive officer were tailored to each
person's specific job. Such criteria included both objective measures of
corporate performance as well as subjective measures of individual performance.
Examples of corporate measurement criteria utilized were new customer contracts,
revenues and net profits. Subjective individual measurement criterion included
product development, customer satisfaction, managerial performance and the
successful accomplishment of special projects. While the various criteria for
each executive officer were given a specific weight in determining bonus
payment, the weighing of the factors differed among the executive officers.

     Based on the Company's inability to attain the threshold level of 1996
annual net income, no executive officer (other than the Vice President of Sales
who was paid on a separate bonus and commission arrangement) received a 1996
performance bonus.

                            LONG-TERM STOCK OPTIONS

     The long-term incentive compensation for executive officers consists of
awards of stock options granted under the Company's 1993 Option Plan. Initial
awards under the 1993 Option Plan are typically made upon the commencement of
employment with the Company and create an incentive to executive officers to
contribute to the long-term growth of the Company's performance. While
additional stock option grants are often made to employees at various times
following initial employment, the Company typically awards annual bonuses to its
executive officers during the first quarter of each year.

     Options are granted at the fair market value of the Company Common Stock on
the day of grant, thus providing a reward only for future stock appreciation. In
addition, options are typically subject to a four-year vesting eligibility to
reinforce a long-term perspective and to help retain valued executives.

     In considering the size of option grants to any individual executive
officer in 1996, the Committee reviewed the overall performance of each
executive officer and also relied upon the recommendations of the executive
compensation Consultant retained by the Company for this purpose.

     In granting option awards, the Committee generally considers existing
stockholdings and prior option grants to those receiving the grants, but does
not view such information as determinative in its decisions. As with the setting
of 1996 base salaries, in granting stock options the Committee heavily relied on
industry comparisons with other publicly held software companies surveyed by the
Consultant.

                                      -6-
<PAGE>
 
                     CHIEF EXECUTIVE OFFICER COMPENSATION

     The Committee considered essentially the same factors and market peer group
for compensation purposes in determining Mr. Sample's base salary in 1996 as
were considered in determining the base salaries for other executive officers.
Consequently, the Committee believes Mr. Sample's 1996 base salary was
approximately the median of salaries for chief executive officers of other
national computer systems and software companies with comparable annual
revenues.

     The Committee is particularly interested in correlating Mr. Sample's
compensation with the overall performance of the Company and the alignment of
Company goals with shareholder interests. As a result, for 1996, the Committee
decided that the CEO would be eligible to receive a performance bonus equal to
50% of his annual base salary. The 50% bonus computation determined by the
Committee was based upon the recommendation of the retained Consultant and
approximated the median salary bonus for CEOs of comparable companies. Such
bonus was conditioned on the attainment of the same threshold target level of
Company net profit as was applicable to the bonus plan criteria of other
executive officers.

     As with other executive officers, if a higher excess level of 1996 annual
net profits before taxes, non-recurring charges and bonus payments was achieved,
then the CEO would be eligible to receive 150% of his target bonus for the year.
As with other executive officers, since the Company did not attain the threshold
net profit for fiscal 1996 required by the bonus plan, Mr. Sample did not
receive a 1996 cash performance bonus.

     In 1996, the Committee granted a stock option to Mr. Sample in the amount
of 15,000 shares. The Committee believed that this additional grant of a stock
option provided him with further long-term incentive to maximize overall return
to shareholders. While the Committee considered the amount and terms of options
and stock already held by Mr. Sample, such information was not determinative.
The stock option granted to Mr. Sample was subjective and represented
approximately one-half of the amount recommended by the Consultant as a median
level of option grant to CEOs of other comparable companies. However, the
Committee anticipates that option grants to him in future years will increase so
as to be comparable with option grants to CEOs of other companies in the
industry.

               POLICY WITH RESPECT TO $1 MILLION DEDUCTION LIMIT

     Section 162(m) of the Internal Revenue Code creates a limit for publicly
held companies on the deductibility of compensation paid to the CEO and the next
four most highly compensated officers in office at the end of the year.
Compensation paid to these officers in excess of $1 million, that is not
performance based, cannot be claimed by the Company as a tax deduction. The
Company believes that its 1993 Option Plan currently qualifies for the
performance-based exception to the $1 million limitation on deductibility of
compensation payments. The Company does not expect that its cash compensation to
its CEO or any of the other four most highly compensated executive officers will
exceed the $1 million limitation during fiscal 1997.

                              Compensation Committee:

                              Timothy J. Wollaeger, Chairman
                              Daniel Dyer
                              Lonnie M. Smith


EMPLOYMENT, TERMINATION AND CHANGE OF CONTROL AGREEMENTS

     Frank T. Sample, President and Chief Executive Officer of the Company, is a
party to an employment agreement (the "Employment Agreement") with the Company
dated November 12, 1990, as amended October 27, 1994. The Employment Agreement
provides for the continuation of Mr. Sample's salary and benefits for one year,
plus payment for reasonable outplacement services, if Mr. Sample is terminated
by the Company or a successor to the Company for any reason.

     Unexercised stock options granted under the Company's 1983 Combined
Nonqualified and Incentive Stock Option Plan (the "1983 Option Plan") terminate
upon the occurrence of certain events, including certain mergers,

                                      -7-
<PAGE>
 
but immediately prior to such a transaction, optionees may exercise such options
without regard to whether the vesting requirements have been satisfied. In a
stock merger where the Company is not the surviving corporation, the options
shall terminate, unless the Company and such other corporation, in their sole
discretion, determine that such options will be converted into options to
purchase shares of the other corporation involved in the merger. The converted
options would be adjusted in the same proportion used for determining the number
of shares of such other corporation the holders of Common Stock would receive in
such merger and shall continue to vest in accordance with the vesting
requirements in the original option agreements.

     Unexercised stock options granted under the 1993 Option Plan terminate upon
the occurrence of certain events, including certain mergers, but immediately
prior to such a transaction, optionees may exercise such options without regard
to whether the vesting requirements have been satisfied. In a stock merger where
the Company is not the surviving corporation, the options convert into options
to purchase shares of the other corporation involved in the merger, unless the
Company and such other corporation, in their sole discretion, determine that
such options shall terminate. The converted options would be fully vested
without regard to whether the vesting requirements in the option agreements have
been satisfied.

     Unexercised stock options under the Nonemployee Director Stock Option Plan
terminate upon the occurrence of certain events, including certain mergers;
however, for a 30-day period immediately prior to such a transaction, optionees
may exercise such options without regard to whether the vesting requirements
have been satisfied.


PERFORMANCE GRAPH

     The following graph compares the cumulative total shareholder return (stock
price appreciation plus reinvested dividends) on the Common Stock against the
cumulative total return of the NASDAQ Total U.S. Index and the NASDAQ Computer
and Data Processing Services Index since the Company became a publicly traded
company on December 16, 1994, and ending on December 31, 1996. The graph assumes
that $100 was invested on December 16, 1994 in each of the Common Stock, the
NASDAQ Total U.S. Index and the NASDAQ Computer and Data Processing Services
Index, and that all dividends were reinvested. Management of the Company
cautions that the stock price performance shown in the graph below should not be
considered indicative of potential future stock price performance.

                    Comparison of Cumulative Total Returns
                      Performance Graph for PHAMIS, Inc.

                                    [GRAPH]


                                    LEGEND
<TABLE>
<CAPTION>
                                              12/16/94    12/31/94    3/31/95    6/30/95     9/30/95
                                              --------    --------    -------    -------     -------
 <S>                                          <C>         <C>         <C>        <C>        <C> 
PHAMIS, Inc.                                   $100.00     $150.00    $181.25    $208.33     $228.13
NASDAQ Composite Index                         $100.00     $105.62    $115.09    $131.65     $147.49
NASDAQ Computer & Data Processing Index        $100.00     $103.12    $116.08    $137.59     $150.29
 
 
                                              12/31/95     3/31/96     6/30/96    9/30/96   12/31/96
                                              --------     -------     -------    -------   --------
 
PHAMIS, Inc.                                   $247.92     $139.58     $122.92    $139.58    $107.29
NASDAQ Composite Index                         $149.25     $156.32     $169.08    $175.10    $183.71
NASDAQ Computer & Data Processing Index        $157.29     $164.39     $182.73    $186.37    $193.91
</TABLE>

                                      -8-
<PAGE>
 
ITEM 12.  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

     The following table sets forth information regarding the beneficial
ownership of Common Stock on March 31, 1997, by (i) each person known by the
Company to beneficially own more than 5 percent of the Common Stock, (ii) each
director, (iii) the Company's Chief Executive Officer and the other executive
officers named in the executive compensation table set forth herein and (iv) all
directors and executive officers as a group. The following is based on
information furnished by such owners. Each of the persons named below has sole
voting and investment power with respect to the shares shown, except as noted
below.

<TABLE>
<CAPTION>
                                                   Shares of
Name and Address                                  Common Stock
of Beneficial Owner                            Beneficially Owned   Percent of Class
- --------------------------------------------   ------------------   -----------------
<S>                                            <C>                  <C>
Kopp Investment Advisors Inc................         808,000/(1)/         13.1%
       6600 France Ave. So., Suite 672
       Edina, MN  55435
GeoCapital Corporation......................         368,500/(2)/         6.0%
       757 Fifth Avenue
       New York, NY  10153
Waddell & Reed, Inc.........................         520,400/(3)/         8.4%
       2001 Third Avenue South
       Birmingham, AL  35233
Malcolm A. Gleser...........................         408,367/(4)/         6.6%
       c/o PHAMIS, Inc.
       1001 Fourth Avenue Plaza, Suite 1500
       Seattle, WA  98154
Daniel Dyer.................................          82,955/(5)/         1.3%
Lonnie M. Smith.............................           3,592/(6)/           *
Timothy J. Wollaeger........................           4,265/(7)/           *
Frank T. Sample.............................         198,303/(8)/         3.2%
Mark F. Wheeler.............................         235,756/(9)/         3.8%
Gregg W. Blodgett...........................          30,733/(10)/          *
Thomas M. Watson............................          36,484/(11)/          *
All directors and executive officers
   as a group (10 persons)..................       1,066,653/(12)/        16.8%
- ----------------------
</TABLE>
* Less than 1%

(1)  Based on information reported in a Schedule 13G filed on January 29, 1997
     by Kopp Investment Advisors, Inc. in which it reported that although it
     exercises investment discretion as to these shares, it does not vote the
     shares and is not the record owner of them.

(2)  Based on information reported in a Schedule 13G filed on February 15, 1997
     by GeoCapital Corporation.

(3)  Based on information reported in a Schedule 13G filed on January 31, 1997
     by Waddell & Reed, Inc.

(4)  Includes an aggregate of 27,429 shares held as trustee for irrevocable
     trusts for the benefit of members of Dr. Wheeler's family; Dr. Gleser
     disclaims beneficial ownership of such shares. Also includes 4,530 shares
     held for Dr. Gleser's benefit under the Company's Salary Savings and
     Deferral Plan (the "401(k) Plan"), and 1,866 shares issuable pursuant to
     stock options exercisable within 60 days of March 31, 1997.

(5)  Includes 2,000 shares issuable pursuant to stock options exercisable within
     60 days of March 31, 1997.

(6)  Includes 1,000 shares issuable pursuant to stock options exercisable within
     60 days of March 31, 1997.

(7)  Includes 2,000 shares issuable pursuant to stock options exercisable within
     60 days of March 31, 1997, and

                                      -9-
<PAGE>
 
     2,265 held by a family trust for the benefit of Mr. Wollaeger and his
     spouse.

(8)  Includes an aggregate of 20,600 shares held as trustee for irrevocable
     trusts for the members of Dr. Gleser's family and other individuals; Mr.
     Sample disclaims beneficial ownership of such shares. Also includes 124,166
     shares issuable pursuant to stock options exercisable within 60 days of
     March 31, 1997, 3,085 shares held for Mr. Sample's benefit under the
     401(k) Plan and 452 shares purchased through the Employee Stock Purchase
     Plan.

(9)  Includes 1,866 shares issuable pursuant to stock options exercisable within
     60 days of March 31, 1997, and 4,194 shares held for Dr. Wheeler's benefit
     under the 401(k) Plan. Does not include 27,429 shares held of record by Dr.
     Gleser as trustee for Dr. Wheeler's children.

(10) Includes 24,615 shares issuable pursuant to stock options exercisable
     within 60 days of March 31, 1997, and 118 shares held for Mr. Blodgett's
     benefit under the 401(k) Plan.

(11) Includes 559 shares held for Mr. Watson's benefit under the 401(k) Plan. In
     February 1997, Mr. Watson resigned from the Company.

(12) Includes, in the aggregate, 180,578 shares issuable pursuant to stock
     options exercisable within 60 days of March 31, 1997, and 16,619 shares
     held for the benefit of members of the group under the 401(k) Plan.


ITEM 14.  EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K

10.3 Amendment to Rights Agreement dated as of March 25, 1997 between PHAMIS,
     Inc. and ChaseMellon Shareholders Services L.L.C. as Rights Agent.

                                      -10-
<PAGE>
 
                                   SIGNATURES


     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this Amendment to Form 10-K for the fiscal year ended
December 31, 1996, to be signed on its behalf by the undersigned, hereunto duly
authorized, on the 22nd day of April, 1997.

PHAMIS, INC.



By:  /s/ GREGG W. BLODGETT
     ---------------------------------------------------------------------------
     Gregg W. Blodgett
     Vice President of Finance and Administration
     Chief Financial Officer and Treasurer

     Pursuant to the requirements of the Securities Act of 1933, as amended,
this Amendment to Form 10-K for the fiscal year ended December 31, 1996 has been
signed by the following persons in the capacities indicated below on the 22nd
day of April, 1997.



     SIGNATURES                                    TITLE
     ----------                                    -----


/s/   FRANK T. SAMPLE*          President, Chief Executive Officer and Director
- ----------------------                  (Principal Executive Officer)
      Frank T. Sample


/s/   GREGG W. BLODGETT         Vice President of Finance and Administration
- -----------------------         Chief Financial Officer and Treasurer
      Gregg W. Blodgett         (Principal Accounting Officer)


                                Chairman of the Board
- -----------------------
      Malcolm A. Gleser


                                Director
- -----------------------
      Daniel Dyer


/s/   LONNIE SMITH*             Director
- -----------------------
      Lonnie Smith


/s/   TIMOTHY J. WOLLAEGER*     Director
- ---------------------------
      Timothy J. Wollaeger


*By      /S/  GREGG W. BLODGETT
      -------------------------
              Gregg W. Blodgett
              Attorney-in-Fact
                                     

                                      -11-

<PAGE>
 
                                                                    EXHIBIT 10.3
 
                         AMENDMENT TO RIGHTS AGREEMENT



     This is an AMENDMENT (the "Amendment"), to the Rights Agreement, dated as
of July 29, 1996 (the "Rights Agreement") between PHAMIS, Inc. (the "Company"),
and Chasemellon Shareholder Services, L.L.C., as successor Rights Agent, (the
"Rights Agent").

     WHEREAS, the Rights Agreement specifies the terms of the Rights (as defined
therein); and

     WHEREAS, the Company and the Rights Agent desire to amend the Rights
Agreement in accordance with Section 26 of the Rights Agreement;

     NOW THEREFORE, in consideration of the premises and mutual agreements set
forth in the Rights Agreement and this Amendment, the parties hereby agree as
follows:

     1. Section 3 of the Rights Agreement is amended to add a new Section 3(d)
at the end thereof as follows:

          "Notwithstanding any other provision of this Agreement, neither the
     execution of the Agreement and Plan of Merger (the "Merger Agreement"),
     dated as of March 25, 1997 and as amended from time to time, among the
     Company, IDX Systems Corporation ("IDX"), and a wholly owned subsidiary of
     IDX, nor the consummation of the Merger or grant of proxies provided for
     therein in accordance with the terms of the Merger Agreement, will cause a
     Stock Acquisition Date or a Distribution Date to occur or cause an event
     set forth in Section 11(a)(ii) or Section 13 hereof to occur."

     2. The term "Agreement" as used in the Rights Agreement shall be deemed to
refer to the Rights Agreement as amended hereby.

     3. This Amendment shall be effective as of this date and, except as set
forth herein, the Rights Agreement shall remain in full force and effect and
shall be otherwise unaffected hereby.

     4. This Amendment may be executed in two counterparts, each of which shall
be deemed an original, but both of which together shall constitute one and the
same instrument.
<PAGE>
 
     DATED as of March 25, 1997.

                              PHAMIS, Inc.



                              By:   /s/ FRANK T. SAMPLE
                                   ---------------------------------------
                                    Name:  Frank T. Sample,
                                    Title: Chief Executive Officer


                              CHASEMELLON SHAREHOLDER
                              SERVICES L.L.C
 

                              By:   /s/  PAULINE F. SKUDLER
                                   -----------------------------
                                    Name:  Pauline F. Skudler
                                    Title: Assistant Vice President


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission